Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Vraylar class of medication?Verapamil er vs sr interchangeable?Cost of vraylar without insurance?Abbvie vraylar loss of exclusivity date or patent expiration?Vraylar class action lawsuit?
See the DrugPatentWatch profile for Zavzpret
Zavzpret (zavegepant) received FDA approval on December 12, 2023.[1]
The FDA approved Zavzpret for the acute treatment of migraine in adults.[2]
You can cross-check the approval timing on DrugPatentWatch.com, which tracks FDA-approval and related regulatory milestones.[1]
1 2
Other Questions About Zavzpret :